Obat-obatan Asia Timur: Tablet Fumarat Vonoralastat Mendapatkan Sertifikat Pendaftaran Obat

K-LinePoet · 2026-03-25T09:33:48+00:00

East Asia Pharmaceutical announced that the company recently received a "Drug Registration Certificate" for Vonoprazan Fumarate Tablets issued and approved by the National Medical Products Administration. Vonoprazan Fumarate is a potassium-competitive acid blocker (P-CAB), which can inhibit gastric acid generation and suppress mucosal damage in the upper gastrointestinal tract. It is mainly used for the treatment of gastroesophageal reflux, and when used in combination with appropriate antibiotics, it can eradicate Helicobacter pylori.

K-LinePoet

2026-03-25 09:33:48

East Asia Pharmaceutical announces that recently, the company received the “Drug Registration Certificate” approved and issued by the National Medical Products Administration for Fumaric VenoLar Tablets. Fumaric VenoLar is a potassium ion competitive acid blocker (P-CAB) that can inhibit gastric acid production and prevent upper gastrointestinal mucosal damage, mainly used to treat gastroesophageal reflux disease (GERD), often in combination with appropriate antibiotics to eradicate Helicobacter pylori.

Lihat Asli

Halaman ini mungkin berisi konten pihak ketiga, yang disediakan untuk tujuan informasi saja (bukan pernyataan/jaminan) dan tidak boleh dianggap sebagai dukungan terhadap pandangannya oleh Gate, atau sebagai nasihat keuangan atau profesional. Lihat Penafian untuk detailnya.

1 Suka